跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KARVEZIDE 300 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
KARVEZIDE 300 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
KARVEZIDE 300 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Sanofi Winthrop Industrie
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 18, 2024
Approval ID
54a28ec467f532c2
Company
Sanofi Winthrop Industrie
Type
Standard
Approval Details
Approval Id
54a28ec467f532c2
Drug Cima Aemps Name
KARVEZIDE 300 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
98085024IP1
Holder Company Name
Sanofi Winthrop Industrie
Marketing Company Name
Difarmed S.L.U.
Holder Company Detail Path
/organization/sanofi-winthrop-industrie
Authorization Date
2024-07-18
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
300 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sanofi Winthrop Industrie
Company Detail Path
/organization/sanofi-winthrop-industrie
Company Information
Pharmaceutical Company Name
SANOFI WINTHROP INDUSTRIE
Country Name
France
City Name
amilly,centre val de loire,country_fr
Address
130 RUE DE LA FONTAINE
Active Ingredients
IRBESARTAN
300 mg
HIDROCLOROTIAZIDA
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 18, 2024
Approval ID
54a28ec467f532c2
Type
Standard
Back to CIMA-AEMPS Approvals